secwatch.observer — SEC 8-K summary
======================================

Issuer:     Damora Therapeutics, Inc. (DMRA)
CIK:        0001800315
Form:       8-K
Filed at:   2023-01-06T23:59:59+00:00
Accession:  0000950170-23-000283
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Galecto reports $66M cash as of Dec 31, 2022; updates corporate presentation
----------------------------------------------------------------------------

- Cash, cash equivalents, and investments of approx. $66M as of Dec. 31, 2022.
- Updated corporate presentation dated Jan. 2023 furnished as an exhibit; no specific details or material changes described.
- No financial or operational guidance provided beyond the cash balance update.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1800315/000095017023000283/0000950170-23-000283-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1800315/000095017023000283/glto-20230106.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-000283

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer